US 10118904
Triazoles for the treatment of Demyelinating Diseases
granted A61KA61K31/4196A61K31/4439
Quick answer
US patent 10118904 (Triazoles for the treatment of Demyelinating Diseases) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61K, A61K31/4196, A61K31/4439, A61K31/454, A61K31/496